Immunofluorescence assay indicated that ADQ significantly decreased the CD206 (M2 phenotype marker) and CXCL1 expression levels in breast tumor tissues, suggesting that ADQ was able to significantly inhibit TAM infiltration and attenuate CXCL1 expression in vivo (Fig. 2b). This evidence concerns the gene CXCL1 and breast neoplasm.